Journal of Applied Physiology Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

J Appl Physiol (August 10, 2006). doi:10.1152/japplphysiol.00255.2006
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
101/6/1685    most recent
00255.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suwa, M.
Right arrow Articles by Kumagai, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suwa, M.
Right arrow Articles by Kumagai, S.
Submitted on February 28, 2006
Accepted on August 7, 2006

Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo

Masataka Suwa1*, Toru Egashira2, Hiroshi Nakano3, Haruka Sasaki4, and Shuzo Kumagai1

1 Institute of Health Science, Kyushu University, Kasuga, Japan
2 Graduate School of Human Environment Studies, Kyushu University, Kasuga, Japan
3 Department of Human Development, Nakamura Gakuen University, Jonan-ku, Japan
4 Second division of Internal Medicine, Chikushi Hospital, Fukuoka University, Chikushino, Japan

* To whom correspondence should be addressed. E-mail: suwa-m{at}students.ihs.kyushu-u.ac.jp.

AMP-activated protein kinase (AMPK), which was activated by an antihyperglycemic drug metformin, has been hypothesized to mediate metabolic adaptations. The purposes of the present study were 1) to confirm whether acute metformin administration induced AMPK phosphorylation, and 2) to determine whether chronic metformin treatment increased the peroxisome proliferator-activated receptor {gamma} coactivator-1{alpha} (PGC-1{alpha}) protein expression, glycolytic and oxidative enzyme activities, and cytochrome C and glucose transporter-4 (GLUT-4) protein expressions in the rat soleus and red and white gastrocnemius muscles. The single oral administration of metformin (300 mg/kg body weight) enhanced the AMPK phosphorylation at 5 and/or 6 hours after treatment. In the chronic study, rats were fed either normal chow or chow containing 1 % metformin for 14 days. Metformin treatment resulted in a mean daily metformin intake of 631 mg/kg body weight/day. Metformin increased the PGC-1{alpha} content in all three muscles. Metformin increased the hexokinase activity in the white gastrocnemius, the citrate synthase activity in all three muscles, and the {beta}-hydroxyacyl CoA dehydrogenase activity in the soleus. The cytochrome C protein content in the soleus muscle also increased. The GLUT-4 content was unchanged by metformin. These results suggest that metformin enhances the PGC-1{alpha} expression and mitochondrial biogenesis possibly at least in part via AMPK phosphorylation in the skeletal muscle. Metformin has thus been proposed to possibly ameliorate insulin resistance, at least partially, by means of such metabolic effects.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
W. S. Kim, Y. S. Lee, S. H. Cha, H. W. Jeong, S. S. Choe, M.-R. Lee, G. T. Oh, H.-S. Park, K.-U. Lee, M. D. Lane, et al.
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E812 - E819.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. A. Rasbach and R. G. Schnellmann
Isoflavones Promote Mitochondrial Biogenesis
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 536 - 543.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. E. Osler and J. R. Zierath
Minireview: Adenosine 5'-Monophosphate-Activated Protein Kinase Regulation of Fatty Acid Oxidation in Skeletal Muscle
Endocrinology, March 1, 2008; 149(3): 935 - 941.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
S. Schiaffino, M. Sandri, and M. Murgia
Activity-Dependent Signaling Pathways Controlling Muscle Diversity and Plasticity
Physiology, August 1, 2007; 22(4): 269 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Jager, C. Handschin, J. St.-Pierre, and B. M. Spiegelman
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha}
PNAS, July 17, 2007; 104(29): 12017 - 12022.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Crunkhorn, F. Dearie, C. Mantzoros, H. Gami, W. S. da Silva, D. Espinoza, R. Faucette, K. Barry, A. C. Bianco, and M. E. Patti
Peroxisome Proliferator Activator Receptor {gamma} Coactivator-1 Expression Is Reduced in Obesity: POTENTIAL PATHOGENIC ROLE OF SATURATED FATTY ACIDS AND p38 MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION
J. Biol. Chem., May 25, 2007; 282(21): 15439 - 15450.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Rasbach and R. G. Schnellmann
Signaling of Mitochondrial Biogenesis following Oxidant Injury
J. Biol. Chem., January 26, 2007; 282(4): 2355 - 2362.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.